112 related articles for article (PubMed ID: 6740188)
1. [Changes in vascular endothelial cells induced by serum from scleroderma and other connective tissue diseases].
Meyer O; Haïm T; Lansaman J; Dryll A; Ryckewaert A
Rev Rhum Mal Osteoartic; 1984 May; 51(5):255-61. PubMed ID: 6740188
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial cell injury in progressive systemic sclerosis and other connective tissue diseases.
Meyer O; Haïm T; Dryll A; Lansaman J; Ryckewaert A
Clin Exp Rheumatol; 1983; 1(1):29-34. PubMed ID: 6442633
[TBL] [Abstract][Full Text] [Related]
3. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases.
Rosenbaum J; Pottinger BE; Woo P; Black CM; Loizou S; Byron MA; Pearson JD
Clin Exp Immunol; 1988 Jun; 72(3):450-6. PubMed ID: 3168322
[TBL] [Abstract][Full Text] [Related]
4. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
5. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis.
Penning CA; Cunningham J; French MA; Harrison G; Rowell NR; Hughes P
Clin Exp Immunol; 1984 Sep; 57(3):548-56. PubMed ID: 6467679
[TBL] [Abstract][Full Text] [Related]
6. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
Bodolay E; Szegedi G
Orv Hetil; 2002 Feb; 143(5):229-33. PubMed ID: 11875835
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of antibodies to a 68 kDa U1RNP polypeptide in connective tissue disease.
McHugh N; James I; Maddison P
J Rheumatol; 1990 Oct; 17(10):1320-8. PubMed ID: 1701488
[TBL] [Abstract][Full Text] [Related]
8. Immunological analysis of pulmonary hypertension in connective tissue diseases.
Nishimaki T; Aotsuka S; Kondo H; Yamamoto K; Takasaki Y; Sumiya M; Yokohari R
J Rheumatol; 1999 Nov; 26(11):2357-62. PubMed ID: 10555891
[TBL] [Abstract][Full Text] [Related]
9. [A possible role of anti-endothelial cell antibody in the sera of MCTD patients on pulmonary vascular damage relating to pulmonary hypertension].
Sasaki N; Kurose A; Inoue H; Sawai T
Ryumachi; 2002 Dec; 42(6):885-94. PubMed ID: 12632608
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiological effects of endothelial cytotoxic activity derived from sera of patients with progressive systemic sclerosis.
Drenk F; Deicher HR
J Rheumatol; 1988 Mar; 15(3):468-74. PubMed ID: 3379623
[TBL] [Abstract][Full Text] [Related]
11. Antinucleolar autoantibodies demonstrated by monolayers of human fibroblasts in sera from patients with systemic lupus erythematosus, progressive systemic sclerosis and chronic active hepatitis.
Kenneally D; Mackay IR; Toh BH
J Clin Lab Immunol; 1984 May; 14(1):13-6. PubMed ID: 6748043
[TBL] [Abstract][Full Text] [Related]
12. [Undifferentiated connective tissue disease].
Bodolay E; Szegedi G
Orv Hetil; 2009 May; 150(19):867-72. PubMed ID: 19403430
[TBL] [Abstract][Full Text] [Related]
13. [Progress in laboratory tests of connective tissue diseases].
Yamane K; Kato S; Sakauchi M
Rinsho Byori; 1989 Dec; 37(12):1311-6. PubMed ID: 2614963
[TBL] [Abstract][Full Text] [Related]
14. Immune complexes in progressive systemic sclerosis and mixed connective tissue disease.
Cunningham PH; Andrews BS; Davis JS
J Rheumatol; 1980; 7(3):301-8. PubMed ID: 7401065
[TBL] [Abstract][Full Text] [Related]
15. [Connective tissue diseases and HEp-2 antinuclear antibodies].
Scagliusi P; Anelli P; Fasiello V; De Lucia M; Pipitone V
Minerva Med; 1985 May; 76(21):999-1003. PubMed ID: 3873632
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive investigation of disease-specific short peptides in sera from patients with systemic sclerosis: complement C3f-des-arginine, detected predominantly in systemic sclerosis sera, enhances proliferation of vascular endothelial cells.
Xiang Y; Matsui T; Matsuo K; Shimada K; Tohma S; Nakamura H; Masuko K; Yudoh K; Nishioka K; Kato T
Arthritis Rheum; 2007 Jun; 56(6):2018-30. PubMed ID: 17530642
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95.
Sgonc R; Gruschwitz MS; Boeck G; Sepp N; Gruber J; Wick G
Arthritis Rheum; 2000 Nov; 43(11):2550-62. PubMed ID: 11083280
[TBL] [Abstract][Full Text] [Related]
18. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines.
Carvalho D; Savage CO; Black CM; Pearson JD
J Clin Invest; 1996 Jan; 97(1):111-9. PubMed ID: 8550821
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic activity of sera from scleroderma and other connective tissue diseases. Lack of cellular and disease specificity.
Shanahan WR; Korn JH
Arthritis Rheum; 1982 Dec; 25(12):1391-5. PubMed ID: 7150374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
